Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: 3 | Vintage Vibes

HCA Healthcare Whale Trades For September 20

Someone with a lot of money to spend has taken a bullish stance on HCA Healthcare (NYSE:HCA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

HCA Healthcare Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on HCA Healthcare. Looking at options history for HCA Healthcare (NYSE:HCA) we detected 15 strange trades.

Benzinga

The $18,000 breast biopsy

The hospital estimated the biopsy would cost $1,400. How did it end up being so much more, even with insurance?

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

The $18,000 breast biopsy: When having insurance costs you a bundle

When Dani Yuengling felt a lump in her right breast last summer, she tried to ignore it.

Tribune News Service

An $18,000 biopsy? Paying cash might have been cheaper than using her insurance

A hospital's cost calculator said her procedure would be $1,400 for patients without insurance. Instead, the bill was almost $18,000 and, her part was more than $5,000 — the balance of her deductible.

WEKU

What Are Whales Doing With HCA Healthcare

A whale with a lot of money to spend has taken a noticeably bearish stance on HCA Healthcare. Looking at options history for HCA Healthcare (NYSE:HCA) we detected 13 strange trades.

Benzinga

This Is What Whales Are Betting On HCA Healthcare

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022

Upgrades

Benzinga

Looking Into HCA Healthcare's Recent Short Interest

HCA Healthcare's (NYSE:HCA) short percent of float has fallen 20.59% since its last report. The company recently reported that it has 5.06 million shares sold short, which is 1.89% of all regular shares that are available for trading.

Benzinga

Where HCA Healthcare Stands With Analysts

Analysts have provided the following ratings for HCA Healthcare (NYSE:HCA) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2022

Upgrades

Benzinga

How Is The Market Feeling About HCA Healthcare?

HCA Healthcare's (NYSE:HCA) short percent of float has risen 16.15% since its last report. The company recently reported that it has 5.00 million shares sold short, which is 2.23% of all regular shares that are available for trading.

Benzinga

Here's How Much $1000 Invested In HCA Healthcare 10 Years Ago Would Be Worth Today

HCA Healthcare (NYSE:HCA) has outperformed the market over the past 10 years by 10.6% on an annualized basis producing an average annual return of 21.36%. Currently, HCA Healthcare has a market capitalization of $55.62 billion.

Benzinga

What 11 Analyst Ratings Have To Say About HCA Healthcare

HCA Healthcare (NYSE:HCA) has observed the following analyst ratings within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Benzinga

This Foreboding Sign Looms Over HCA Healthcare's Chart

If history is any guide, there may be trouble ahead for shares of HCA Healthcare (NYSE:HCA). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Executives Buy Over $373M Of 4 Stocks

Although crude oil futures traded higher on Thursday, there were a few notable insider trades.

Benzinga

Here's How Much You Would Have Made Owning HCA Healthcare Stock In The Last 10 Years

HCA Healthcare (NYSE:HCA) has outperformed the market over the past 10 years by 10.58% on an annualized basis producing an average annual return of 22.24%. Currently, HCA Healthcare has a market capitalization of $62.02 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why This Analyst Thinks HCA Healthcare Was 'Well Oversold' After Revised Outlook

RBC Capital Market reduced the target price for HCA Healthcare Inc (NYSE:HCA) from $291 to $267 (26.5% upside), noting the shares were well oversold on Friday (-22%) after a ~5.5% guide-down on known labor headwinds. The analysts continue to view the labor backdrop as largely transitory and believe HCA management is well equipped to…

Benzinga

Analyst Ratings for HCA Healthcare

Within the last quarter, HCA Healthcare (NYSE:HCA) has observed the following analyst ratings:

Benzinga

HCA Healthcare's Softer Guidance Pulls Hospital Peers Down

Earlier today HCA Healthcare Inc (NYSE: HCA) reported Q1 earnings and cut FY22 guidance. The revised outlook is based on current expectations regarding the impact of the COVID-19 pandemic and related government legislation, labor cost, and inflation.

Benzinga

Earnings Preview For HCA Healthcare

HCA Healthcare (NYSE:HCA) is set to give its latest quarterly earnings report on Friday, 2022-04-22. Here's what investors need to know before the announcement. Analysts estimate that HCA Healthcare will report an earnings per share (EPS) of $4.25.

Benzinga

What 4 Analyst Ratings Have To Say About HCA Healthcare

Over the past 3 months, 4 analysts have published their opinion on HCA Healthcare (NYSE:HCA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022

Upgrades

StockNews.com

5 Value Stocks to Reinforce Your Portfolio in Q2 2022

Due to concerns over the possibility of aggressive interest rate increases and the consequences of a prolonged Ukraine-Russia war, current market volatility has caused many quality stocks to trade at attractive valuations. For example, fundamentally sound stocks Lockheed Martin (LMT), HCA Healthcare (HCA), FedEx (FDX), Enterprise Products (EPD), and Walgreens…

1 2 3 4

People

Ge Bai

15 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.